Literature DB >> 16372018

KLF4, p21 and context-dependent opposing forces in cancer.

Benjamin D Rowland1, Daniel S Peeper.   

Abstract

Krüppel-like factors are transcriptional regulators that influence several cellular functions, including proliferation. Recent studies have shown that one family member, KLF4, can function both as a tumour suppressor and an oncogene. The ability of KLF4 to affect the levels of expression of the cell-cycle regulator p21 seems to be involved, in that this protein might function as a switch that determines the outcome of KLF4 signalling. Is this role of p21 restricted to KLF4, or does p21 represent a nodal point for signals from multiple other factors with opposing functions in cancer?

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372018     DOI: 10.1038/nrc1780

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  234 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

Review 2.  Krüppel-like transcription factors in the nervous system: novel players in neurite outgrowth and axon regeneration.

Authors:  Darcie L Moore; Akintomide Apara; Jeffrey L Goldberg
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

3.  A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context.

Authors:  Chen-Chung Lin; Ling-Zhi Liu; Joseph B Addison; William F Wonderlin; Alexey V Ivanov; J Michael Ruppert
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

4.  ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4.

Authors:  Myoung Ok Kim; Sung-Hyun Kim; Yong-Yeon Cho; Janos Nadas; Chul-Ho Jeong; Ke Yao; Dong Joon Kim; Dong-Hoon Yu; Young-Sam Keum; Kun-Yeong Lee; Zunnan Huang; Ann M Bode; Zigang Dong
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

Review 5.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

6.  Initial analysis of copy number variations in cattle selected for resistance or susceptibility to intestinal nematodes.

Authors:  George E Liu; Twain Brown; Deborah A Hebert; Maria Francesca Cardone; Yali Hou; Ratan K Choudhary; Jessica Shaffer; Chinwendu Amazu; Erin E Connor; Mario Ventura; Louis C Gasbarre
Journal:  Mamm Genome       Date:  2010-12-03       Impact factor: 2.957

7.  ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.

Authors:  Ryota Otsuka; Yasunori Akutsu; Haruhito Sakata; Naoyuki Hanari; Kentaro Murakami; Masayuki Kano; Takeshi Toyozumi; Masahiko Takahashi; Yasunori Matsumoto; Nobufumi Sekino; Masaya Yokoyama; Koichiro Okada; Tadashi Shiraishi; Aki Komatsu; Keiko Iida; Hisahiro Matsubara
Journal:  Oncology       Date:  2017-12-08       Impact factor: 2.935

8.  miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

Authors:  Hiroshi Okuda; Fei Xing; Puspa R Pandey; Sambad Sharma; Misako Watabe; Sudha K Pai; Yin-Yuan Mo; Megumi Iiizumi-Gairani; Shigeru Hirota; Yin Liu; Kerui Wu; Radhika Pochampally; Kounosuke Watabe
Journal:  Cancer Res       Date:  2013-02-05       Impact factor: 12.701

Review 9.  Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.

Authors:  Vaishali Aggarwal; Kumari Priyanka; Hardeep Singh Tuli
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

10.  Expression of Krüppel-like factor 4 in breast cancer tissues and its effects on the proliferation of breast cancer MDA-MB-231 cells.

Authors:  Xiang Song; Yue-Ming Xing; Wei Wu; Guo-Hua Cheng; Feng Xiao; Gang Jin; Ying Liu; Xin Zhao
Journal:  Exp Ther Med       Date:  2017-03-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.